U.S. markets open in 3 hours 8 minutes

iRhythm Technologies, Inc. (IRTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
89.58-1.36 (-1.50%)
At close: 4:00PM EDT

90.96 +1.38 (1.54%)
Pre-Market: 4:38AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close90.94
Bid0.00 x 900
Ask0.00 x 800
Day's Range88.77 - 92.11
52 Week Range77.43 - 286.19
Avg. Volume795,367
Market Cap2.612B
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • iRhythm Technologies, Inc. (NASDAQ:IRTC) Analysts Just Cut Their EPS Forecasts Substantially
    Simply Wall St.

    iRhythm Technologies, Inc. (NASDAQ:IRTC) Analysts Just Cut Their EPS Forecasts Substantially

    The analysts covering iRhythm Technologies, Inc. ( NASDAQ:IRTC ) delivered a dose of negativity to shareholders today...

  • Why iRhythm Technologies Stock Is Crashing Today
    Motley Fool

    Why iRhythm Technologies Stock Is Crashing Today

    Novitas' new Medicare reimbursement rates translate to significantly lower revenue for the cardiac care company.

  • TheStreet.com

    iRhythm Plunges as Novitas Updates Medicare Reimbursement Rate

    Shares of ambulatory electrocardiogram monitoring device maker iRhythm Technologies fell sharply after Medicare contractor Novitas updated reimbursement rates for coding related to iRhythm's ZioXT service. While the new rates represent an increase from previous rates, iRhythm says it believes they don't appropriately reflect the clinical and economic value that long-term continuous electrocardiogram monitoring offers patients. The company says that due to the cost of providing the service relative to the updated rates published by Novitas, it won't be able to provide its Zio XT service to the Medicare fee-for-service segment if rates remain the same.